EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synergistic Activity of Cefiderocol in Combination with Avibactam, Sulbactam or Tazobactam against Carbapenem-Resistant Gram-Negative Bacteria

Russell E Lewis, Marta Palombo, Erica Diani iD, Benedetta Secci, Davide Gibellini, Paolo Gaibani iD

Cells · 06.08.2024 · 13 (16) · 1315

DOI: 10.3390/cells13161315 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 06.08.2024. Verfasst von Russell E Lewis und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, University of Padova, 35122 Padova, Italy. Hauptthemen laut MEDLINE: Azabicyclo Compounds, Tazobactam, Sulbactam, Drug Synergism. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FUR2024.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We investigated the activity of cefiderocol/β-lactamase inhibitor combinations against clinical strains with different susceptibility profiles to cefiderocol to explore the potentiality of antibiotic combinations as a strategy to contain the major public health problem of multidrug-resistant (MDR) pathogens. Specifically, we evaluated the synergistic activity of cefiderocol with avibactam, sulbactam, or tazobactam on three of the most “Critical Priority” group of MDR bacteria (carbapenem-resistant Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii). Clinical isolates were genomically characterized by Illumina iSeq 100. The synergy test was conducted with time-kill curve assays. Specifically, cefiderocol/avibactam, /sulbactam, or /tazobactam combinations were analyzed. Synergism was assigned if bacterial grow reduction reached 2 log10 CFU/mL. We reported the high antimicrobial activity of the cefiderocol/sulbactam combination against carbapenem-resistant Enterobacterales, P. aeruginosa, and A. baumannii; of the cefiderocol/avibactam combination against carbapenem-resistant Enterobacterales; and of the cefiderocol/tazobactam combination against carbapenem-resistant Enterobacterales and P. aeruginosa. Our results demonstrate that all β-lactamase inhibitors (BLIs) tested are able to enhance cefiderocol antimicrobial activity, also against cefiderocol-resistant isolates. The cefiderocol/sulbactam combination emerges as the most promising combination, proving to highly enhance cefiderocol activity in all the analyzed carbapenem-resistant Gram-negative isolates, whereas the Cefiderocol/tazobactam combination resulted in being active only against carbapenem-resistant Enterobacterales and P. aeruginosa, and cefiderocol/avibactam was only active against carbapenem-resistant Enterobacterales.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Azabicyclo CompoundsTazobactamSulbactamDrug SynergismCephalosporinsMicrobial Sensitivity TestsAnti-Bacterial AgentsCefiderocolGram-Negative BacteriaCarbapenemsHumansAcinetobacter baumanniiPseudomonas aeruginosabeta-Lactamase InhibitorsDrug Resistance, Multiple, BacterialDrug Combinations

Stichwörter der Autor:innen

carbapenem-resistant Acinetobacter baumanniicarbapenem-resistant Enterobacterialescarbapenem-resistant Pseudomonas aeruginosacefiderocol/avibactamcefiderocol/sulbactamcefiderocol/tazobactam

Substanzen

Azabicyclo CompoundsTazobactamSulbactamavibactamCephalosporinsAnti-Bacterial AgentsCefiderocolCarbapenemsbeta-Lactamase InhibitorsDrug Combinations

Autor:innen und Institutionen

  • Department of Molecular Medicine, University of Padova, 35122 Padova, Italy.
  • IRCCS Azienda Ospedaliero, Universitaria di Bologna, 40135 Bologna, Italy.
  • Department of Diagnostic and Public Health, Microbiology Section, Verona University, 37134 Verona, Italy.

ORCID-Profile: Erica Diani, Paolo Gaibani

Förderung

  • FUR2024

Zitieren

APA

Lewis, R. E., Palombo, M., Diani, E., Secci, B., Gibellini, D., & Gaibani, P. (2024). Synergistic Activity of Cefiderocol in Combination with Avibactam, Sulbactam or Tazobactam against Carbapenem-Resistant Gram-Negative Bacteria. Cells, 13(16), 1315. https://doi.org/10.3390/cells13161315

Vancouver

Lewis RE, Palombo M, Diani E, Secci B, Gibellini D, Gaibani P. Synergistic Activity of Cefiderocol in Combination with Avibactam, Sulbactam or Tazobactam against Carbapenem-Resistant Gram-Negative Bacteria. Cells. 2024;13(16):1315. doi:10.3390/cells13161315

BibTeX
@article{Lewis2024,
  author = {Lewis, Russell E and Palombo, Marta and Diani, Erica and Secci, Benedetta and Gibellini, Davide and Gaibani, Paolo},
  title = {Synergistic Activity of Cefiderocol in Combination with Avibactam, Sulbactam or Tazobactam against Carbapenem-Resistant Gram-Negative Bacteria},
  journal = {Cells},
  year = {2024},
  volume = {13},
  number = {16},
  pages = {1315},
  doi = {10.3390/cells13161315}
}
Kostenlos starten →